Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
The head of the Food and Drug Administration cited a long commute and time away from family as reasons to step down.
The high cost of hepatitis C treatment in the U.S. is about to see a major shift to lower prices of the major leading hepatitis C treatments
The drugs are set to come out in January 2019 with a list price of $24,000 for the most common dose for each.
This Ukrainian woman didn’t let outdated hepatitis C treatment or limited access to them, prevent her from getting necessary medical care.
Stocks of drug companies are rising—and that’s not a good sign for consumers.
Invoking a 100-year-old law that was implemented to serve folks in a time of crisis.
Research from the 2016 Liver Meeting
Groups purchasing treatment from buyers’ clubs do well on the drugs.
A discussion about insurance coverage of hepatitis C treatment
Generic versions of major hepatitis C drugs are apparently very effective.
Researchers are launching trials of a $300 generic hepatitis C regimen that could help expand treatment of the virus in poorer nations.
Pretty snappy heading, isn’t it. But it’s what I actually did. Via Twitter. So I got a lot of the info and got to skip the queues for taxis.
Lawyers argue that the formula for sofosbuvir was based on “old science” and that the patent should be rejected.
It’s been 6 months since my treatment was completed and last Friday I went and got blood taken for my 24 week post treatment viral load.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.